SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-006412
Filing Date
2018-05-09
Accepted
2018-05-09 16:56:33
Documents
47
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnlo033118q110-q.htm 10-Q 983486
2 EXHIBIT 31.1 exhibit311.htm EX-31.1 16331
3 EXHIBIT 31.2 exhibit312.htm EX-31.2 16620
4 EXHIBIT 32.1 exhibit321.htm EX-32.1 12979
  Complete submission text file 0001628280-18-006412.txt   3907428

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mnlo-20180331.xml EX-101.INS 734787
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnlo-20180331.xsd EX-101.SCH 26474
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnlo-20180331_cal.xml EX-101.CAL 53173
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnlo-20180331_def.xml EX-101.DEF 128285
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnlo-20180331_lab.xml EX-101.LAB 375262
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnlo-20180331_pre.xml EX-101.PRE 206138
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 18819164
SIC: 2834 Pharmaceutical Preparations